Posted on February 21st, 2013 by Logan Lafferty
More research on AUDs for pediatric epilepsy is critical, according to Raj D. Sheth, M.D., chief of neurology at Mayo Clinic College of Medicine in Jacksonville, FL. “The lack of information makes it difficult for neurologists, who have to prescribe off label; difficult for the insurance companies, who often restrict medications if they’re not clearly FDA approved; and very difficult for pediatric patients, because they are denied use of medications that older people are able to take.
Neurology Now by Olga Rukovets
You must be logged-in to the site to post a comment.